When the INCB Annual Report for 2007 – under embargo until March 5 – started to circulate about a month ago, I was in complete shock after reading the worst ever paragraphs on coca written in UN history for several decades. The position taken by the Board now can be characterized by no more talk about the need to solve 'long-standing ambiguities in the conventions', not a shred of sympathy anymore for traditional customs or rights of indigenous peoples, no trace of cultural sensitivity at all, an all-out attack against coca chewing, drinking of coca tea or any other uses of coca in its natural form in the Andean region and the northern parts of Argentina and Chile.
Bolivia will ask the United Nations to organize a conference on coca leaf-chewing if the U.S., Britain and Sweden don't withdraw their objections to the country's efforts to drop the ban on the age-old practice in an international treaty, Bolivia's U.N. ambassador said Friday.
The International Guiding Principles on Alternative Development approved last week at an international meeting in Lima, Peru, represents a lost opportunity to promote equitable economic development in some of the world’s poorest regions. The final document on the Guiding Principles bears little resemblance to the document that was originally drafted in November 2011 in Thailand by a group of more than 100 governmental and non-governmental experts.
The admission by UN's lead agency for drugs, the UNODC, that “the drug market is thriving” in its 2017 World Drug Report is an important one given that it is months away from 2019 – the target date by which governments committed to “significantly reduce or eliminate” the global drug market. At the recent annual gathering of the Commission on Narcotic Drugs (CND) in Vienna, this abysmal failure to claim any progress towards these ‘drug-free’ targets was the backdrop to the latest round of tense negotiations on global drug control.
Prohibitionist policies based on the eradication of production and on the disruption of drug flows as well as on the criminalization of consumption have not yielded the desired results. We are further than ever from the announced goal of eradicating drugs.
Breaking the taboo, acknowledging the failure of current policies and their consequences is the inescapable prerequisite for the discussion of a new paradigm leading to safer, more efficient and humane drug policies.
In 1945, the United Nations was established to 'save succeeding generations from the scourge of war.' Today, the language of war has been adopted for policy objectives. The 'war on drugs' is now more widespread and higher in financial and human cost than ever, and has impacted negatively across borders and across human rights protections. The war on drugs has left in its wake human rights abuses, worsening national and international security and barriers to sustainable development.
The UN General Assembly Special Session (UNGASS) on drugs – held in New York in April 2016 – was hailed as an opportunity for the international community ‘to conduct a wide-ranging and open debate that considers all options’. Although the UNGASS was characterised by many shortcomings and disappointments, it was nonetheless a critical moment for global drug policy reform.
The International Conference on the Reduction of Drug Related Harmsis taking place in Barcelona, May 11-15. UN Special Rapporteur on the Right to Health, Paul Hunt, made an excellent keynote speech addressing the multiple violations of the human rights of people who use drugs. Our Hungarian friends from the HCLU taped his speech on video.
In a surprise ruling yesterday, the British Colombia Supreme Court supported Vancouver's experimental supervised injection clinic Insite - North America's first legal supervised injection site - and halted federal attempts to close the facility. That is very good news, but the ruling went even further.
The Commission on Narcotic Drugs (CND) in Vienna will decide next week between two opposite proposals by China and the WHO about international control of ketamine, an essential anaesthetic in human and veterinary medicine. China originally proposed bringing ketamine under the 1971 Convention’s most severe control regime of Schedule I, which would dramatically affect its availability for surgery in poor rural settings and emergency situations. The WHO Expert Committee reviewed all the evidence and advised against any international control of ketamine, arguing it would trigger a public health disaster.
United Nations General Assembly Special Session on the World Drug Problem (UNGASS) New York, 8-10 June 1998
The "United Nations General Assembly Special Session on the World Drug Problem" held from 8 to 10 June in New York, did not bring any surprises. The drug summit adopted a global strategy to reduce illicit drug supply and demand by 2008. In the General Assembly room, it was an uninterrupted three day sequence of political speeches. All countries could give their own emphasis to the agenda items and present in seven minutes their own more general view on the drugs issue and their policies to deal with it. But, all in all, it has been a lost opportunity, no evaluation of current drug policies took place whatsoever, it was devoted to (as a New York Times editorial phrased it) "recycling unrealistic pledges".
The current trend towards legal regulation of the cannabis market has become irreversible and requires an urgent dialogue by UN member states on the best models for protecting people’s health and safety, argues a new report. The question facing the international community today is no longer whether there is a need to revise the UN drug control system, but rather when and how to do it.
This briefing paper summarises the proceedings and outcomes of the 2007 CND. It includes a discussion of a wide range of issues - from technical debates on the rescheduling of dronabinol, to the plans for the global review of the 1998 UNGASS objectives - and comments on the performance of the UN agencies in this field, and of the workings of the CND itself.
Earlier this week, 7-9 July, 300 delegates met in Vienna for the Beyond 2008 NGO Forum meant to provide civil society input for the 10-year UNGASS review. It was the culmination of a series of regional NGO consultations that took place over the past six months all across the globe. Given the wide range of views held by NGOs many – including myself – were sceptical about the outcomes of the process. Would it really be possible to agree by consensus on a joint declaration and resolutions? Well, we did it…
Conflicting views and policies within the UN system on harm reduction have become a major concern. Consistency in messages is crucial especially where it concerns joint global programmes such as the efforts to slow down the HIV/AIDS epidemic; efforts in which harm reduction practices like needle exchange and substitution treatment play a pivotal role.
An October statement on drug control from the US State Department has prompted much comment and speculation at home and abroad. Delivered by Ambassador William Brownfield, the ‘Brownfield Doctrine’, as it has been named by some commentators, lays out a four pillar approach the United States will follow in matters of international drug control.
The International Narcotics Control Board yesterday presented its annual report for 2010. Every year the Board selects a thematic issue of focus, dedicating its opening chapter to that issue. This year it is corruption. In an earlier blog post we asked whether the INCB would have the impartiality to be able to look at the drug control system itself, and its role in the generation of corruption, as the UNODC had done in 2008. The answer is no. At no point is the international criminal market in drugs recognised as a creation of drug control.
Daniel Wolfe, director of the International Harm Reduction Development Program, director of Open Society Foundations Global Drug Policy Program
04 March 2013
In what has become a chilling annual exercise, the UN's drug watchdog the International Narcotics Control Board released its annual report today. The INCB describes itself as a "quasi-judicial" group of experts charged with monitoring compliance with international drug control treaties, but the report's drug war bias and egregious omissions makes us wonder who is judging the judges.